vs
Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and Fabrinet (FN). Click either name above to swap in a different company.
Fabrinet is the larger business by last-quarter revenue ($1.1B vs $950.5M, roughly 1.2× Astrana Health, Inc.). Fabrinet runs the higher net margin — 9.9% vs 0.7%, a 9.3% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs 35.9%). Fabrinet produced more free cash flow last quarter ($-5.3M vs $-6.0M). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs 24.4%).
Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.
FabrinetFNEarnings & Financial Report
Below is a list of companies having stocks that are included in the S&P MidCap 400 stock market index. The index, maintained by S&P Dow Jones Indices, comprises the common stocks of 400 mid-cap, mostly American, companies. Although called the S&P 400, the index sometimes contains more than 400 stocks when it includes two or more share classes of stock from one of its component companies.
ASTH vs FN — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $950.5M | $1.1B |
| Net Profit | $6.6M | $112.6M |
| Gross Margin | — | 12.2% |
| Operating Margin | 1.9% | 10.1% |
| Net Margin | 0.7% | 9.9% |
| Revenue YoY | 42.9% | 35.9% |
| Net Profit YoY | 184.4% | 30.0% |
| EPS (diluted) | $0.12 | $3.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $950.5M | $1.1B | ||
| Q3 25 | $956.0M | $978.1M | ||
| Q2 25 | $654.8M | $909.7M | ||
| Q1 25 | $620.4M | $871.8M | ||
| Q4 24 | $665.2M | $833.6M | ||
| Q3 24 | $478.7M | $804.2M | ||
| Q2 24 | $486.3M | $753.3M | ||
| Q1 24 | $404.4M | $731.5M |
| Q4 25 | $6.6M | $112.6M | ||
| Q3 25 | $373.0K | $95.9M | ||
| Q2 25 | $9.4M | $87.2M | ||
| Q1 25 | $6.7M | $81.3M | ||
| Q4 24 | $-7.8M | $86.6M | ||
| Q3 24 | $16.1M | $77.4M | ||
| Q2 24 | $19.2M | $81.1M | ||
| Q1 24 | $14.8M | $80.9M |
| Q4 25 | — | 12.2% | ||
| Q3 25 | — | 11.9% | ||
| Q2 25 | — | 12.2% | ||
| Q1 25 | — | 11.7% | ||
| Q4 24 | — | 12.1% | ||
| Q3 24 | — | 12.3% | ||
| Q2 24 | — | 12.3% | ||
| Q1 24 | — | 12.4% |
| Q4 25 | 1.9% | 10.1% | ||
| Q3 25 | 2.0% | 9.6% | ||
| Q2 25 | 3.1% | 9.8% | ||
| Q1 25 | 3.3% | 9.0% | ||
| Q4 24 | 0.1% | 9.5% | ||
| Q3 24 | 5.9% | 9.6% | ||
| Q2 24 | 6.2% | 9.7% | ||
| Q1 24 | 7.5% | 9.7% |
| Q4 25 | 0.7% | 9.9% | ||
| Q3 25 | 0.0% | 9.8% | ||
| Q2 25 | 1.4% | 9.6% | ||
| Q1 25 | 1.1% | 9.3% | ||
| Q4 24 | -1.2% | 10.4% | ||
| Q3 24 | 3.4% | 9.6% | ||
| Q2 24 | 3.9% | 10.8% | ||
| Q1 24 | 3.7% | 11.1% |
| Q4 25 | $0.12 | $3.11 | ||
| Q3 25 | $0.01 | $2.66 | ||
| Q2 25 | $0.19 | $2.41 | ||
| Q1 25 | $0.14 | $2.25 | ||
| Q4 24 | $-0.14 | $2.38 | ||
| Q3 24 | $0.33 | $2.13 | ||
| Q2 24 | $0.40 | $2.22 | ||
| Q1 24 | $0.31 | $2.21 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $429.5M | $960.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $779.3M | $2.2B |
| Total Assets | $2.2B | $3.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $429.5M | $960.8M | ||
| Q3 25 | $463.4M | $968.8M | ||
| Q2 25 | $342.1M | $934.2M | ||
| Q1 25 | $260.9M | $950.7M | ||
| Q4 24 | $290.8M | $934.6M | ||
| Q3 24 | $350.3M | $908.9M | ||
| Q2 24 | $327.7M | $858.6M | ||
| Q1 24 | $337.3M | $794.0M |
| Q4 25 | $779.3M | $2.2B | ||
| Q3 25 | $775.5M | $2.1B | ||
| Q2 25 | $765.5M | $2.0B | ||
| Q1 25 | $745.4M | $1.9B | ||
| Q4 24 | $712.7M | $1.8B | ||
| Q3 24 | $704.6M | $1.8B | ||
| Q2 24 | $678.9M | $1.7B | ||
| Q1 24 | $653.5M | $1.7B |
| Q4 25 | $2.2B | $3.3B | ||
| Q3 25 | $2.2B | $3.0B | ||
| Q2 25 | $1.4B | $2.8B | ||
| Q1 25 | $1.3B | $2.6B | ||
| Q4 24 | $1.4B | $2.5B | ||
| Q3 24 | $1.3B | $2.4B | ||
| Q2 24 | $1.3B | $2.3B | ||
| Q1 24 | $1.2B | $2.2B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.9M | $46.3M |
| Free Cash FlowOCF − Capex | $-6.0M | $-5.3M |
| FCF MarginFCF / Revenue | -0.6% | -0.5% |
| Capex IntensityCapex / Revenue | 0.3% | 4.6% |
| Cash ConversionOCF / Net Profit | -0.44× | 0.41× |
| TTM Free Cash FlowTrailing 4 quarters | $104.5M | $102.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.9M | $46.3M | ||
| Q3 25 | $10.0M | $102.6M | ||
| Q2 25 | $90.9M | $55.1M | ||
| Q1 25 | $16.6M | $74.2M | ||
| Q4 24 | $-10.9M | $115.9M | ||
| Q3 24 | $34.0M | $83.2M | ||
| Q2 24 | $23.2M | $83.1M | ||
| Q1 24 | $6.0M | $100.9M |
| Q4 25 | $-6.0M | $-5.3M | ||
| Q3 25 | $7.4M | $57.3M | ||
| Q2 25 | $89.5M | $4.7M | ||
| Q1 25 | $13.6M | $45.7M | ||
| Q4 24 | $-13.5M | $94.0M | ||
| Q3 24 | $31.7M | $62.9M | ||
| Q2 24 | $20.4M | $70.4M | ||
| Q1 24 | $5.6M | $87.3M |
| Q4 25 | -0.6% | -0.5% | ||
| Q3 25 | 0.8% | 5.9% | ||
| Q2 25 | 13.7% | 0.5% | ||
| Q1 25 | 2.2% | 5.2% | ||
| Q4 24 | -2.0% | 11.3% | ||
| Q3 24 | 6.6% | 7.8% | ||
| Q2 24 | 4.2% | 9.3% | ||
| Q1 24 | 1.4% | 11.9% |
| Q4 25 | 0.3% | 4.6% | ||
| Q3 25 | 0.3% | 4.6% | ||
| Q2 25 | 0.2% | 5.5% | ||
| Q1 25 | 0.5% | 3.3% | ||
| Q4 24 | 0.4% | 2.6% | ||
| Q3 24 | 0.5% | 2.5% | ||
| Q2 24 | 0.6% | 1.7% | ||
| Q1 24 | 0.1% | 1.9% |
| Q4 25 | -0.44× | 0.41× | ||
| Q3 25 | 26.69× | 1.07× | ||
| Q2 25 | 9.65× | 0.63× | ||
| Q1 25 | 2.48× | 0.91× | ||
| Q4 24 | — | 1.34× | ||
| Q3 24 | 2.11× | 1.07× | ||
| Q2 24 | 1.21× | 1.02× | ||
| Q1 24 | 0.40× | 1.25× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
FN
| Optical Communications | $832.6M | 73% |
| Non Optical Communications | $300.3M | 27% |
